These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24533894)

  • 1. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China.
    Qing-ping S; Xiao-dong J; Feng D; Yan L; Mei-ling Y; Jin-xiu Z; Shu-qiang Z
    BMC Health Serv Res; 2014 Feb; 14():73. PubMed ID: 24533894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria.
    Oshikoya KA; Chukwura H; Njokanma OF; Senbanjo IO; Ojo I
    Sao Paulo Med J; 2011 May; 129(3):153-64. PubMed ID: 21755250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions reported to the drug and poison information center of Tehran, Iran.
    Saheb Sharif-Askari F; Saheb Sharif-Askari N; Javadi M; Gholami K
    PLoS One; 2017; 12(9):e0185450. PubMed ID: 28950006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.
    Rosli R; Ming LC; Abd Aziz N; Manan MM
    PLoS One; 2016; 11(6):e0155385. PubMed ID: 27249414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017.
    Morales-Ríos O; Cicero-Oneto C; García-Ruiz C; Villanueva-García D; Hernández-Hernández M; Olivar-López V; Jiménez-Juárez RN; Jasso-Gutiérrez L
    PLoS One; 2020; 15(3):e0230576. PubMed ID: 32208451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions.
    Kuula LSM; Backman JT; Blom ML
    Pharmacol Res Perspect; 2022 Apr; 10(2):e00931. PubMed ID: 35170862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.
    Vázquez-Alvarez AO; Brennan-Bourdon LM; Rincón-Sánchez AR; Islas-Carbajal MC; Huerta-Olvera SG
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):79. PubMed ID: 29216902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China.
    Du R; Wang X; Ma L; Larcher LM; Tang H; Zhou H; Chen C; Wang T
    BMC Cancer; 2021 Feb; 21(1):206. PubMed ID: 33639888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors.
    Pérez-Ingidua C; Rivas-Paterna AB; González-Perrino C; Aleo-Luján E; Ascaso-Del-Rio A; Laredo-Velasco L; Portolés-Pérez A; Vargas-Castrillón E
    BMC Pediatr; 2024 May; 24(1):344. PubMed ID: 38760745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit.
    Shaikh S; Raut A; Jambhale P; Iyer S; Shah J
    Curr Drug Saf; 2024; 19(3):332-341. PubMed ID: 37587829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the reporting of adverse drug reactions in children and adolescents in Germany in the time period from 2000 to 2019.
    Leitzen S; Dubrall D; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
    PLoS One; 2021; 16(3):e0247446. PubMed ID: 33657139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012-2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate.
    Beeler PE; Stammschulte T; Dressel H
    Drug Saf; 2023 Aug; 46(8):753-763. PubMed ID: 37335465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia.
    Walter SR; Day RO; Gallego B; Westbrook JI
    Br J Clin Pharmacol; 2017 Feb; 83(2):416-426. PubMed ID: 27614089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India.
    Haile DB; Ayen WY; Tiwari P
    Ethiop J Health Sci; 2013 Mar; 23(1):39-48. PubMed ID: 23559837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.
    Impicciatore P; Choonara I; Clarkson A; Provasi D; Pandolfini C; Bonati M
    Br J Clin Pharmacol; 2001 Jul; 52(1):77-83. PubMed ID: 11453893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Impact of Hospital-Acquired Adverse Drug Reactions in Older Adults: An Australian Cohort Study.
    Inglis JM; Medlin S; Bryant K; Mangoni AA; Phillips CJ
    J Am Med Dir Assoc; 2024 Aug; 25(8):105083. PubMed ID: 38878799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010-2016.
    Beauchamp GA; Amaducci A; Greenberg MR; Meyers M; Cook M; Cannon RD; Katz KD; Finkelstein Y;
    J Med Toxicol; 2019 Oct; 15(4):262-270. PubMed ID: 31309522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
    Rhodes NJ; Dairem A; Moore WJ; Shah A; Postelnick MJ; Badowski ME; Michienzi SM; Borkowski JL; Polisetty RS; Fong K; Spivak ES; Beardsley JR; Hale CM; Pallotta AM; Srinivas P; Schulz LT
    Am J Health Syst Pharm; 2021 Mar; 78(7):568-577. PubMed ID: 33537767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical coding of prospectively identified paediatric adverse drug reactions--a retrospective review of patient records.
    Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
    BMC Pharmacol Toxicol; 2014 Dec; 15():72. PubMed ID: 25519049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.